ArticleOncotarget2017

Glucose-6-phosphate dehydrogenase and transketolase modulate breast cancer cell metabolic reprogramming and correlate with poor patient outcome.

Adrián Benito et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.